Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
RESEARCH TOOLSreports
Holding KALV?
Track your performance easily
KalVista Pharmaceuticals (KALV) Ownership Overview
11.27% Insiders
15.23% Mutual Funds
0.15% Other Institutional Investors
9.80% ETFs
63.54% Public Companies and Individual Investors
The ownership structure of KalVista Pharmaceuticals (KALV) stock is a mix of institutional, retail, and individual investors. Approximately 25.18% of the company’s stock is owned by Institutional Investors, 11.27% is owned by Insiders, and 63.54% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 16, 2024 | Benjamin L Palleiko Ceo,director | xxxxxxxxxxxxx | $612825 |
| Feb 16, 2024 | xxxxxxxxxxxxx | $598290 | |
| Feb 16, 2024 | xxxxxxxxxxxxx | $422565 | |
| Feb 16, 2024 | Thomas Andrew Crockett Ceo,director | xxxxxxxxxxxxx | $875340 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $153492 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $281648 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $7043569 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,824,731 | Insider | 9.76% | 37,922,386 | |
| 3,374,064 | Institution | 6.83% | 26,520,143 | |
| 2,146,358 | Institution | 4.34% | 16,870,374 | |
| 1,765,004 | Institution | 3.57% | 13,872,931 | |
| 1,628,535 | Institution | 3.30% | 12,800,285 | |
| 692,408 | Institution | 1.40% | 5,442,327 | |
| 608,253 | Institution | 1.23% | 4,780,869 | |
| 535,717 | Institution | 1.08% | 4,210,736 | |
| 500,000 | Institution | 1.01% | 3,930,000 | |
| 419,555 | Institution | 0.85% | 3,297,702 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,374,064 | Institution | 6.83% | 26,520,143 | |
| 1,765,004 | Institution | 3.57% | 13,872,931 | |
| 419,555 | Institution | 0.85% | 3,297,702 | |
| 352,988 | Institution | 0.71% | 2,774,486 | |
| 341,503 | Institution | 0.69% | 2,684,214 | |
| 336,667 | Institution | 0.68% | 2,646,203 | |
| 200,212 | Institution | 0.41% | 1,573,666 | |
| 194,062 | Institution | 0.39% | 1,525,327 | |
| 127,300 | Institution | 0.26% | 1,000,578 | |
| 110,720 | Institution | 0.22% | 870,259 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,398,334 | Institution | 2.83% | 14,067,240 | |
| 928,862 | Institution | 1.88% | 7,300,855 | |
| 607,394 | Institution | 1.23% | 4,494,716 | |
| 524,672 | Institution | 1.06% | 5,278,200 | |
| 316,633 | Institution | 0.64% | 2,488,735 | |
| 205,729 | Institution | 0.42% | 1,617,030 | |
| 180,399 | Institution | 0.37% | 1,814,814 | |
| 98,377 | Institution | 0.20% | 727,990 | |
| 79,141 | Institution | 0.16% | 622,048 | |
| 74,553 | Institution | 0.15% | 551,692 |
FAQ
Who Owns KalVista Pharmaceuticals (KALV)?
According to the latest TipRanks data, approximately 0.15% of the company's stock is held by institutional investors, 11.27% is held by insiders, and 63.54% is held by retail investors.
What percentage of KalVista Pharmaceuticals (KALV) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.15% of KalVista Pharmaceuticals (KALV) stock is held by institutional investors.
What percentage of KalVista Pharmaceuticals (KALV) stock is held by retail investors?
According to the latest TipRanks data, approximately 63.54% of KalVista Pharmaceuticals (KALV) stock is held by retail investors.
Who owns the most shares of KalVista Pharmaceuticals (KALV)?
Venrock Healthcare Capital Partners III, L.P. owns the most shares of KalVista Pharmaceuticals (KALV).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.